ECG Software

CIHR, Industry and Heart and Stroke funded study will start with in-pharmacy screening in October 2014 Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced it has completed its technology placement for the Canadian Stroke Prevention Intervention Network … Read more

Screening efforts designed to increase awareness and provide education of the warning signs and implications of Atrial Fibrillation as a risk factor for stroke. TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) CardioComm Solutions and the Heart and Stroke Foundation are working together to implement the Company’s SMART Monitoring based … Read more

ECG Modernization Project Links CardioComm Solutions to the FAA Aviation Medical Examiner (AME) Community TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed that it has been listed as a cloud services provider under the launch of the Federal Aviation Administration (“FAA”) Civil Aerospace Medical Institute ECG Modernization project. … Read more

Web-Presence will introduce the HeartCheck™ device to a global network of patients and affiliate organizations TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced an agency agreement with Arrhythmia Alliance based out of the United Kingdom.  The … Read more

Active sales and marketing efforts of GEMS™ WIN as a Windows 7 compatible ECG management software nets new license agreements from a wide array of customers TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that sales of its new Global ECG Management System release (GEMS™  WIN), a Windows … Read more

Company Shifts Focus from R&D to Increased Resourcing of ECG Software Sales and Customer Support TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), today announced operations and sales team changes intended to drive inside-sales through upgrading the Company’s medical software customers to the new Windows 7 compatible Global ECG Management … Read more

Web-based site provides access to the HeartCheck™ PEN by Canadians who are without easy access to pharmacies TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced a distribution agreement with Toronto-based PHARMACY.CA, for internet-based sales of the … Read more

Joint Venture will provide CardioComm Solutions with an equity position in Vigilance and recurrent licensing revenues TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions has executed a binding Letter of Intent with Vigilance, Inc. to develop and co-market … Read more

HeartCheck™ Technologies to be used to identify people at risk for potentially life-threatening drug side effects TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced it has entered into a partnership agreement with the Clinical Neuroendocrinology Laboratory … Read more

Clearance opens the way for HeartCheck™ Device Sales and SMART Monitoring ECG Services in China TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, confirms that China’s Food and Drug Administration (“CFDA”) has cleared the HeartCheck™ PEN ECG device … Read more